333180

Product Features

Bd oncomark anti-hla-dr fitc/cd13 pe is intended for in vitro flow cytometric immunophenotyping this reagent combination can be used to analyze myeloid lineage development; anti-hla-dr and cd13 assays are used in the diagnosis of hematologic disorders; the antibody reagent is stable until the expiration date shown on the label when stored at 2 to 8 degree celsius; bd oncomark anti-hla-dr fitc/cd13 pe can be used for immunophenotyping by flow cytometry woth peripheral blood and bone marrow aspirates collected in edta (eg, bd vacutainer tubes); each type of specimen can have different storage conditions and limitations that should be considered prior to collection and analysis

Detail Specifications